| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b05b5989ddb554f42eb30cd74341011e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd3d5cc3409f8df59cc7e890b10256b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eee5c13ecf26b3644c1d9b50259a64ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_160cd2c4cc578495573eccaa8f68d53a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2218-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00702 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00 |
| filingDate |
2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e51fc4ad3d9586ff4a9bf06b36d2c4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43d2b32af4c2309ff55bc5333a9557c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cbef25fffabb586319f957e66b596e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae998b2ce3e36a97cece4d6cbdf6dcc |
| publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012150171-A1 |
| titleOfInvention |
Controlling Coagulum Formation |
| abstract |
Some embodiments of a medical instrument can be configured to reduce the formation of coagulum by delivering a negative charge bias to conductive surfaces that interface with blood or bodily tissue during a medical procedure. The application of the negative charge at the instrument-blood interface can reduce the fibrinogen deposition and the formation of coagulum because fibrinogen molecules in general are negatively charged at neutral pH levels. In addition, some embodiments of the instrument may be configured to irrigate the instrument-blood interface with RGD/C1fA peptides, a bicarbonate solution (or other high pH solution), or both to further repel the fibrinogen and thereby inhibit the formation of coagulum. Accordingly, some embodiments of the medical instrument can substantially reduce the risks of thromboembolism during particular medical procedures. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022145554-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220099095-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020188559-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102551847-B1 |
| priorityDate |
2006-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |